PETALING JAYA: Duopharma Biotech Bhd’s earnings prospects are expected to be supported by improved market penetration and growing demand in key Asean markets along with the recent reduction in the overnight policy rate. Read full story
Date: 13 November, 2025 9:01 pm
Source: thestar.com.my
💬 Join the Conversation! 💬
We’ve disabled comments on our posts and pages to keep the discussions organized and lively! But don’t worry – the conversation isn’t over. Head over to our forum and share your thoughts, ideas, and feedback with the community! It’s the perfect place to connect, learn, and engage with others who care about the same things. We can’t wait to hear from you!